Sitemap
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82
Posts
- Category: Breast Cancer
- (No Title)
- "Hair To Stay" - UCSF Tests Promising Solutions For Cancer Hair Loss
- 'Cause Marketing' Blurs Line Between Product, Cause, Columnist Writes
- 'Engineered Organ' Model For Breast Cancer Research
- 'Junk' DNA Reveals Key Information About Breast Cancer Risk And Development
- 102nd Annual Meeting Of The American Association For Cancer Research
- 19th Annual Congress On Women's Health To Explore Mammography Controversy
- 45% Of Breast Tumors Destroyed With Pertuzumab And Herceptin Combo Plus Chemotherapy Docetaxel
- A New Standard Treatment For Breast Cancer At Early Stages To Be Established By Spanish Oncology
- Addition Of Bevacizumab To Conventional Therapy Improved Progression-Free Survival In HER2-Positive Breast Cancer
- AltheaDx And Compendia Bioscience Launch The Breast Cancer Segregation Panel™
- Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data At SABCS
- An Earlier Start On Diagnosing Breast, Prostate Cancers
- Analysis Of Evidence On Breast Cancer Screening At Odds With Recent USPSTF Recommendations
- Annual Breast Cancer Screening Beginning At Age 40 Reduces Mastectomy Risk
- Annual Screening For Women With Breast Cancer Family History May Save Lives
- Annually Breast Cancer Screening Younger Women Lowers Mastectomy Risk
- Antibiotic Slows Growth Of Bladder, Breast Cancer Cells
- Aromatase Inhibitors Increased Risk Of Heart Disease In Postmenopausal Women With Breast Cancer
- ARUP Laboratories Announces Availability Of A New Laboratory Developed Test For Subtyping Breast Cancer
- Association Between Hormone Therapy Begun At Menopause And Risk For Breast Cancer
- Avastin (bevacizumab) Not Safe And Effective In Breast Cancer, Says FDA
- AVEO's Tivozanib In Combination With Paclitaxel Demonstrates Safety In Patients With Metastatic Breast Cancer
- Avesthagen Completes The First Whole Genome Sequence Of A Parsi Breast Cancer Patient
- Avoidable Breast Cancer Risk Factors Identified
- Bionovo Announces Publication Describing Estrogen Receptor Beta Cancer Prevention Mechanism
- BioTheranostics' Breast Cancer Index(SM) Predicts Risk For Late Recurrence In Early Stage ER-Positive Breast Cancer Patients
- Black And Hispanic Women With Breast Cancer Face Treatment Delays
- Blogs Comment On Sexism In Politics, Safe Abortion Week, Other Topics
- Body Fat Distribution Associated With A Higher Risk Of ER-Negative Breast Cancer
- Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib In Advanced Breast Cancer
- Breast Biopsies And Microbubble Ultrasound
- Breast Cancer Cells Outsmart The Immune System And Thrive
- Breast Cancer Controversy Laid To Rest: Analyzing Sentinel Lymph Node For Further Tiny Tumors Has Little Prognostic Value
- Breast Cancer Mortality And Progression Worse For Smokers Or Ex-Smokers
- Breast Cancer Patients With Diabetes More Likely To Die
- Breast Cancer Patients With Strong Social Network Live Longer
- Breast Cancer Risk In Postmenopausal Osteoporotic Women Reduced By Lasofoxifene
- Breast Cancer Screenings In Mexico Rise Sharply After Awareness Campaign
- Breast Cancer Survivors At Greater Risk Of Painful Hip Fractures
- Breast Cancer Survivors Often Rate Post-Treatment Breast Appearance Only "Fair"
- Breast Cancer Symposium Features Prevention, Recurrence Research
- Breast Cancer: I-SPY 2 Study To Speed Up Treatment
- Breast Cancer: PIT(-1)ting Good And Bad Outcomes Against Each Other
- Breast CT Imaging System Marches Forward As Pain-Free Tool To Aid Mammograms
- Breast Inflammation Is Key To Cancer Growth
- British Study Suggests Changes To U.K. Breast Cancer Screenings For Women In 40s
- Cancer Treatment Centers Of America® Midwestern Regional Medical Center Receives 'Gold Standard' In Accreditation For Its Breast Cancer Program
- Chance Of Early Discontinuation Of Breast Cancer Therapy Increased By Higher Co-Payments
